Skip to main content

Drug Analysis

Volume 453: debated on Tuesday 28 November 2006

To ask the Secretary of State for Health if she will direct the Medicines and Healthcare Products Regulatory Agency to publish on its website drug analysis prints containing details of yellow card reports submitted after 25 May; and if she will make a statement. (103135)

The Medicines and Health Regulations Agency (MHRA) are committed to making drug safety information derived from the yellow card scheme as accessible as possible. To this end, in January 2005 the MHRA published aggregated, anonymised data summarising the suspected adverse drug reactions (ADRs) reported for all medicines on its website. The information has been updated to include ADR data up to 26 May 2006. This information is available at:

The MHRA is currently implementing a major upgrade of the drug safety monitoring database and data reporting systems. This upgrade includes a review of the presentation of aggregated drug safety information with a view to making the information easier to interpret. Subsequent to this redesign, the MHRA will update the adverse drug reaction data on its website on a three-monthly cycle.